Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss
9 April 2024
No Comments
Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), announced
Tag: vector genomes
